Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 289
6
Diseases
58
Unique genes
0.135
Avg. similarity score
Cervical disc degenerative disorder
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Cervical disc degenerative disorder
Intervertebral disc disease
Berylliosis
Gouty arthritis
Trigeminal neuralgia
Uremia
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Cervical disc degenerative disorder | 5 | 5 | 6 |
| Intervertebral disc disease | 5 | 5 | 10 |
| Berylliosis | 2 | 2 | 10 |
| Gouty arthritis | 2 | 2 | 15 |
| Trigeminal neuralgia | 2 | 2 | 12 |
| Uremia | 2 | 2 | 18 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TGFB1 | 5 / 6 | Berylliosis, Cervical disc degenerative disorder, Gouty arthritis, Intervertebral disc disease and 1 more |
| IL1B | 4 / 6 | Cervical disc degenerative disorder, Gouty arthritis, Intervertebral disc disease, Trigeminal neuralgia |
| TNF | 4 / 6 | Berylliosis, Cervical disc degenerative disorder, Intervertebral disc disease, Trigeminal neuralgia |
| SPARC | 3 / 6 | Cervical disc degenerative disorder, Intervertebral disc disease, Uremia |
| ASPN | 2 / 6 | Cervical disc degenerative disorder, Intervertebral disc disease |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| AGE-RAGE signaling pathway in diabetic complications | KEGG | 13 / 101 | 26.7× | 1.10e-15 | 4.22e-13 ✓ sig. |
| Th17 cell differentiation | KEGG | 12 / 109 | 22.8× | 1.06e-13 | 2.69e-11 ✓ sig. |
| Rheumatoid arthritis | KEGG | 11 / 95 | 24.0× | 7.02e-13 | 1.58e-10 ✓ sig. |
| Chagas disease | KEGG | 11 / 103 | 22.1× | 1.74e-12 | 3.65e-10 ✓ sig. |
| Human T-cell leukemia virus 1 infection | KEGG | 13 / 224 | 12.0× | 3.51e-11 | 5.59e-9 ✓ sig. |
| Tuberculosis | KEGG | 12 / 181 | 13.7× | 4.65e-11 | 7.23e-9 ✓ sig. |
| Toll-like receptor signaling pathway | KEGG | 10 / 109 | 19.0× | 9.04e-11 | 1.31e-8 ✓ sig. |
| Pertussis | KEGG | 9 / 78 | 23.9× | 1.05e-10 | 1.51e-8 ✓ sig. |
| Focal adhesion | KEGG | 12 / 203 | 12.2× | 1.77e-10 | 2.43e-8 ✓ sig. |
| TNF signaling pathway | KEGG | 10 / 119 | 17.4× | 2.18e-10 | 2.91e-8 ✓ sig. |
| Lipid and atherosclerosis | KEGG | 12 / 216 | 11.5× | 3.64e-10 | 4.58e-8 ✓ sig. |
| Activation of the AP-1 family of transcription factors | Reactome | 5 / 10 | 104× | 5.45e-10 | 6.56e-8 ✓ sig. |
| PI3K-Akt signaling pathway | KEGG | 14 / 361 | 8.0× | 1.17e-9 | 1.28e-7 ✓ sig. |
| Osteoclast differentiation | KEGG | 10 / 142 | 14.6× | 1.25e-9 | 1.36e-7 ✓ sig. |
| MAPK signaling pathway | KEGG | 13 / 299 | 9.0× | 1.26e-9 | 1.36e-7 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| positive regulation of T cell proliferation | GO:0042102 | 8 / 67 | 38.5× | 2.95e-11 | 9.58e-9 ✓ sig. |
| positive regulation of neuroinflammatory response | GO:0150078 | 5 / 16 | 101× | 1.03e-9 | 2.29e-7 ✓ sig. |
| positive regulation of gene expression | GO:0010628 | 13 / 504 | 8.3× | 3.57e-9 | 6.91e-7 ✓ sig. |
| positive regulation of ERK1 and ERK2 cascade | GO:0070374 | 9 / 201 | 14.4× | 1.09e-8 | 1.84e-6 ✓ sig. |
| inflammatory response | GO:0006954 | 12 / 467 | 8.3× | 1.62e-8 | 2.60e-6 ✓ sig. |
| skeletal system development | GO:0001501 | 8 / 151 | 17.1× | 2.05e-8 | 3.20e-6 ✓ sig. |
| positive regulation of epithelial to mesenchymal transition | GO:0010718 | 6 / 59 | 32.8× | 2.72e-8 | 4.06e-6 ✓ sig. |
| positive regulation of MAPK cascade | GO:0043410 | 9 / 224 | 12.9× | 2.78e-8 | 4.12e-6 ✓ sig. |
| response to lipopolysaccharide | GO:0032496 | 8 / 161 | 16.0× | 3.39e-8 | 4.87e-6 ✓ sig. |
| positive regulation of mononuclear cell migration | GO:0071677 | 3 / 4 | 242× | 1.13e-7 | 1.34e-5 ✓ sig. |
| regulation of blood pressure | GO:0008217 | 6 / 83 | 23.3× | 2.15e-7 | 2.31e-5 ✓ sig. |
| embryo implantation | GO:0007566 | 5 / 48 | 33.6× | 3.73e-7 | 3.66e-5 ✓ sig. |
| vascular endothelial growth factor production | GO:0010573 | 3 / 6 | 161× | 5.64e-7 | 5.18e-5 ✓ sig. |
| positive regulation of glial cell proliferation | GO:0060252 | 4 / 22 | 58.6× | 5.86e-7 | 5.35e-5 ✓ sig. |
| positive regulation of miRNA transcription | GO:1902895 | 5 / 56 | 28.8× | 8.17e-7 | 7.05e-5 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cervical disc degenerative disorder | Intervertebral disc disease | 0.417 | 5 | 2.10e-16 | 3.49e-15 ✓ sig. |
| Berylliosis | Cervical disc degenerative disorder | 0.133 | 2 | 5.69e-6 | 3.09e-5 ✓ sig. |
| Cervical disc degenerative disorder | Trigeminal neuralgia | 0.118 | 2 | 8.34e-6 | 4.40e-5 ✓ sig. |
| Cervical disc degenerative disorder | Gouty arthritis | 0.100 | 2 | 1.33e-5 | 6.83e-5 ✓ sig. |
| Berylliosis | Intervertebral disc disease | 0.105 | 2 | 1.70e-5 | 8.62e-5 ✓ sig. |
| Cervical disc degenerative disorder | Uremia | 0.087 | 2 | 1.93e-5 | 9.70e-5 ✓ sig. |
| Intervertebral disc disease | Trigeminal neuralgia | 0.095 | 2 | 2.50e-5 | 1.23e-4 ✓ sig. |
| Gouty arthritis | Intervertebral disc disease | 0.083 | 2 | 3.97e-5 | 1.92e-4 ✓ sig. |
| Intervertebral disc disease | Uremia | 0.074 | 2 | 5.78e-5 | 2.34e-4 ✓ sig. |